Hepatic Veno-Occlusive Disease - 12 Studies Found
| Active, not recruiting |
: Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation : Hepatic Veno-Occlusive Disease : 2013-05-30 : Drug: Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU Other Name: Antithrombin-III Human 500 |
| Completed |
: Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study : Hepatic Veno-Occlusive Disease : 2008-02-25 :
|
| Completed |
: Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients : Severe Hepatic Veno-Occlusive Disease : 2006-07-28 : Drug: Defibrotide Defibrotide 6.25 mg/kg i.v. administered four times a day via 2 hour continuous infusi |
| No longer available |
: Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver : Hepatic Veno-occlusive Disease : 2005-09-01 : Drug: Defibrotide Defibrotide to be administered approximately every 6 hours at an initial dose of 6.25 |
| Completed |
: European VOD Registry : Hepatic Veno-Occlusive Disease : 2017-01-24 |
| Completed |
: Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide : Hepatic Veno-Occlusive Disease : 2006-01-04 :
|
| Completed |
: Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study : Sinusoidal Obstruction Syndrome : 2017-04-24 : Other: Serial Blood Draws Day 0 and Day 3 blood draw for SOS biomarkers. If subject develops SOS blood d |
| Completed |
: Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants :
|
| Completed |
: Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients : Veno-occlusive Disease : 2016-07-27 :
|
| Not yet recruiting |
: Using Ultrasound Elastography to Predict Development of SOS :
|